Quick Summary:
Master the intricacies of the burgeoning Sterile Injectable Drugs market with our comprehensive market research report. Anticipated to scale a noteworthy height of US$1.3 Trillion by 2030, it beholds substantial growth opportunities for forward-thinking business leaders. The market, currently pegged at US$596.2 Billion, presents an encouraging scenario especially for investments in the Small Molecule and Large Molecule segments.
Venture into high growth markets like the U.S., currently estimated at US$181.6 Billion, and China, projected to flourish at a CAGR of 9.1% reaching US$213 Billion by 2030. Our report dissects the multi-faceted aspects of this dynamic market, granting insight into key competitors, market shares, and more. Significantly, gain a distinct competitive edge with special features including online interactive peer-to-peer collaborative bespoke updates and one-year complimentary updates. Ensure your approach to the Sterile Injectable Drugs market is informed, intelligent, and strategic. Invest in our report today for a profitable tomorrow.
Global Sterile Injectable Drugs Market to Reach $1.3 Trillion by 2030
The global market for Sterile Injectable Drugs estimated at US$596.2 Billion in the year 2022, is projected to reach a revised size of US$1.3 Trillion by 2030, growing at a CAGR of 9.7% over the analysis period 2022-2030. Small Molecule, one of the segments analyzed in the report, is projected to record 9.5% CAGR and reach US$522.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Large Molecule segment is readjusted to a revised 9.9% CAGR for the next 8-year period.
The U.S. Market is Estimated at $181.6 Billion, While China is Forecast to Grow at 9.1% CAGR
The Sterile Injectable Drugs market in the U.S. is estimated at US$181.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$213 Billion by the year 2030 trailing a CAGR of 9.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9.3% and 7.9% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.Select Competitors (Total 42 Featured) -
- AstraZeneca PLC
- Gilead Sciences, Inc.
- GlaxoSmithKline PLC
- Pfizer, Inc.
- Science, Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and the publisher's Research Platform
- Complimentary updates for one year
What is the estimated value of the Global Market for Sterile Injectable Drugs?
What is the growth rate of the Global Market for Sterile Injectable Drugs?
What is the forecasted size of the Global Market for Sterile Injectable Drugs?
Who are the key companies in the Global Market for Sterile Injectable Drugs?
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | December 2023 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 596.2 Billion |
| Forecasted Market Value ( USD | $ 1300 Billion |
| Compound Annual Growth Rate | 10.2% |
| Regions Covered | Global |
Table of Contents
Companies Mentioned
A selection of companies mentioned in this report includes:
- AstraZeneca PLC
- Gilead Sciences, Inc.
- GlaxoSmithKline PLC
- Pfizer, Inc.
- Science, Inc.
